Published in Synapse on January 01, 2008
Renal dopamine receptors, oxidative stress, and hypertension. Int J Mol Sci (2013) 0.96
Variants of the RELA gene are associated with schizophrenia and their startle responses. Neuropsychopharmacology (2011) 0.91
Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J Neurochem (2008) 1.37
Human evidence of a supra-spinal modulating role of dopamine on pain perception. Synapse (2009) 1.35
CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. J Neurosci (2011) 1.17
Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system. J Neurochem (2011) 1.14
Proven infection-related sepsis induces a differential stress response early after ICU admission. Crit Care (2010) 1.03
No relationship between the ins del polymorphism of the serotonin transporter promoter and pain perception in fibromyalgia patients and healthy controls. Eur J Pain (2010) 1.03
The chemokine CCL2 increases Nav1.8 sodium channel activity in primary sensory neurons through a Gβγ-dependent mechanism. J Neurosci (2011) 1.02
Central delivery of Dicer-substrate siRNA: a direct application for pain research. Mol Ther (2008) 0.99
Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats. Physiol Behav (2011) 0.98
DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls. J Pain (2009) 0.96
Behavioral, medical imaging and histopathological features of a new rat model of bone cancer pain. PLoS One (2010) 0.96
Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries. Brain Behav Immun (2012) 0.96
Prevalence of claims-based recurrent low back pain in a Canadian population: a secondary analysis of an administrative database. BMC Musculoskelet Disord (2013) 0.94
Case report: clozapine given in the context of chemotherapy for lung cancer. Psychooncology (2008) 0.92
Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model. J Neurochem (2007) 0.91
Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2. Mol Pharmacol (2004) 0.90
Mammary cancer bone metastasis follow-up using multimodal small-animal MR and PET imaging. J Nucl Med (2013) 0.90
Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain. Behav Brain Res (2012) 0.89
Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity. Mol Pain (2009) 0.89
Epithelial BMP signaling is required for proper specification of epithelial cell lineages and gastric endocrine cells. Am J Physiol Gastrointest Liver Physiol (2011) 0.89
Pain perception in schizophrenia: evidence of a specific pain response profile. Pain Med (2012) 0.88
[Long-acting injectable antipsychotics: an expert opinion from the Association des médecins psychiatres du Québec]. Can J Psychiatry (2011) 0.88
Spinal NTS2 receptor activation reverses signs of neuropathic pain. FASEB J (2013) 0.85
Elucidation of the structure-activity relationships of apelin: influence of unnatural amino acids on binding, signaling, and plasma stability. ChemMedChem (2011) 0.84
Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compound. J Med Chem (2014) 0.84
NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization. Biochem Biophys Res Commun (2006) 0.83
Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties. J Clin Invest (2014) 0.83
Regional and subcellular distribution of the receptor-targeting protein PIST in the rat central nervous system. J Comp Neurol (2012) 0.83
Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2. Endocrinology (2007) 0.82
Genomic and proteomic strategies to identify novel targets potentially involved in learning and memory. Trends Pharmacol Sci (2010) 0.81
Identification of N-[(5-{[(4-methylphenyl)sulfonyl]amino}-3-(trifluoroacetyl)-1H-indol-1-yl)acetyl]-l-leucine (NTRC-824), a neurotensin-like nonpeptide compound selective for the neurotensin receptor type 2. J Med Chem (2014) 0.80
α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia. J Mol Neurosci (2012) 0.80
Intermolecular cross-talk between NTR1 and NTR2 neurotensin receptor promotes intracellular sequestration and functional inhibition of NTR1 receptors. Biochem Biophys Res Commun (2009) 0.80
Loss of quinone reductase 2 function selectively facilitates learning behaviors. J Neurosci (2010) 0.80
C-Terminal modifications of apelin-13 significantly change ligand binding, receptor signaling, and hypotensive action. J Med Chem (2015) 0.79
Modulation of canine cardiac sodium current by Apelin. J Mol Cell Cardiol (2009) 0.79
Stability and degradation patterns of chemically modified analogs of apelin-13 in plasma and cerebrospinal fluid. Biopolymers (2014) 0.78
A micro-imaging study linking bone cancer pain with tumor growth and bone resorption in a rat model. Clin Exp Metastasis (2012) 0.78
Implication of the ERK/MAPK pathway in antipsychotics-induced dopamine D2 receptor upregulation and in the preventive effects of (±)-α-lipoic acid in SH-SY5Y neuroblastoma cells. J Mol Neurosci (2013) 0.77
Identification and functional characterization of a 5-transmembrane domain variant isoform of the NTS2 neurotensin receptor in rat central nervous system. J Biol Chem (2005) 0.77
Antipsychotic-induced DRD2 upregulation and its prevention by α-lipoic acid in SH-SY5Y neuroblastoma cells. Synapse (2010) 0.77
Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study. Psychiatry Res (2013) 0.77
Combination of prenatal immune challenge and restraint stress affects prepulse inhibition and dopaminergic/GABAergic markers. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.76
Protracted, dose-dependent weight loss after addition of ziprasidone to a stable regimen of clozapine. Hum Psychopharmacol (2010) 0.76
The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study. Schizophr Res Treatment (2013) 0.76
Immunohistochemical distribution and subcellular localization of the somatostatin receptor subtype 1 (sst1) in the rat hypothalamus. Neurochem Res (2006) 0.76
Capgras syndrome in the modern era: self misidentification on an ID picture. Can J Psychiatry (2005) 0.75
Apelin Compared With Dobutamine Exerts Cardioprotection and Extends Survival in a Rat Model of Endotoxin-Induced Myocardial Dysfunction. Crit Care Med (2017) 0.75
ELABELA Improves Cardio-Renal Outcome in Fatal Experimental Septic Shock. Crit Care Med (2017) 0.75
A case-control study of patients with resistant schizophrenia after clozapine discontinuation. J Clin Psychopharmacol (2007) 0.75
Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder. Schizophr Res (2008) 0.75